Cargando…
Personalized collection of plasma from healthy donors: A randomized controlled trial of a novel technology‐enabled nomogram
BACKGROUND: Source plasma is essential to support the growing demand for plasma‐derived medicinal products. Supply is short, with donor availability further limited by the coronavirus disease 2019 (COVID‐19) pandemic. This study examined whether a novel, personalized, technology‐based nomogram was n...
Autores principales: | Hartmann, Jan, Ragusa, Michael J., Burchardt, Elmar R., Manukyan, Zorayr, Popovsky, Mark A., Leitman, Susan F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251497/ https://www.ncbi.nlm.nih.gov/pubmed/33760230 http://dx.doi.org/10.1111/trf.16389 |
Ejemplares similares
-
The healthy donor effect and survey participation, becoming a donor and donor career
por: Brodersen, Thorsten, et al.
Publicado: (2022) -
Donor and non‐donor perspectives on receiving information from routine genomic testing of donor blood
por: Thorpe, Rachel, et al.
Publicado: (2022) -
Do deferred donors continue their donations? A large‐scale register study on whole blood donor return in the Netherlands
por: Spekman, Marloes L.C., et al.
Publicado: (2019) -
Deferral rate variability in blood donor eligibility assessment
por: de Kort, Wim, et al.
Publicado: (2018) -
Sexual risk behavior questions: Understanding and mitigating donor discomfort
por: Haw, Jennie, et al.
Publicado: (2021)